GLP-1 medications can cause side effects, especially in the early weeks
ambiguous mappings were resolved using OpenAI GPT-4o ( with summary statistics as context, followed by manual verification
IGF-1 LR3 is the primary protein involved in responses of cells to growth hormone (GH): that is, IGF-I is produced in response to GH and then induces cellular activities
To draw a 1mg dose, you need 0.2ml, which equals 20 units on a standard U-100 insulin syringe
Lifelong Treatment Concerns Many patients regain weight after stopping GLP-1 therapy, which can make long-term dependence on medication feel discouraging
16 Dysfunction in brain cell types Inflammation is tightly tied to conditions such as Alzheimers disease, Parkinsons disease, and other dementias